- Clinical Center
- Medical Oncology
- Gynecologic Oncology
- Traditional Chinese Medicine/Integrative Oncology
- Radiation Oncology
- Medical Laboratory
Add: 283 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, P.R. China
Education & Professional Experiences:
in radionuclide therapy clinical work more than 20 years, has a wealth of clinical experience, specializes in differentiated thyroid carcinoma 131 iodine treatment, prostate cancer, breast cancer and other tumors of bone metastases radionuclide therapy, 125 iodine seed implantation, 131I monoclonal antibody therapy.
Good 131I labeled monoclonal antibody targeted radioimmunotherapy cancer, 125I seed implantation of malignant grain, 125I seed grain knife treatment refractory thyroid cancer and metastases, and other new technologies.
The national core journals published more than 30 articles, book one, presided over the Ministry of Health and the Provincial Science and Technology Department issues each one, and launched a personalized treatment chip radionuclide study molecular pathogenesis of thyroid cancer and Risk factors for thyroid cancer cell inactivation promoting differentiation and radionuclide therapy toxicology studies.
1. Radioactive iodine particles 125 head and neck cancer recurrence term efficacy of the treatment of 35 cases
2.131 iodine joint zoledronic acid in the treatment of thyroid cancer bone metastasis retrospective cohort study
3. hyperthyroidism iodine 131 treatment progress and controversy
4. Different treatment of thyroid cancer survival analysis
5. diagnosis and treatment of diseases of Clinical Oncology
multiple advanced workers, research and innovation award, the provincial Medical Association Outstanding Paper Award
Monday, Friday all day